Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis

Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum., 31, 315, 10.1002/art.1780310302 Cooper, 1968, Free immunoglobulin light chains in connective tissue diseases, Ann. Rheum. Dis., 27, 537, 10.1136/ard.27.6.537 Cotton, 2003, MRI contrast uptake in new lesions in relapsing–remitting MS followed at weekly intervals, Neurology, 60, 640, 10.1212/01.WNL.0000046587.83503.1E De Milito, 2004, Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection, Blood, 103, 2180, 10.1182/blood-2003-07-2375 Elovaara, 1991, Increased occurrence of free immunoglobulin light chains in cerebrospinal fluid and serum in human immunodeficiency virus-1 infection, J. Neuroimmunol., 35, 65, 10.1016/0165-5728(91)90162-Z Felson, 1993, The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials, Arthritis Rheum., 36, 729, 10.1002/art.1780360601 Filomena, 1989, Oligoclonal banding detected by urinary protein electrophoresis and immunofixation in two patients with the acquired immune deficiency syndrome and proteinuria, Clin. Chem., 35, 1795, 10.1093/clinchem/35.8.1795 Franciotta, 2008, B cells and multiple sclerosis, Lancet Neurol., 7, 852, 10.1016/S1474-4422(08)70192-3 Freedman, 2005, Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement, Arch. Neurol., 62, 865, 10.1001/archneur.62.6.865 Ghose, 1973, Immunoglobulins in aqueous humour and iris from patients with endogenous uveitis and patients with cataract, Br. J. Ophthalmol., 57, 897, 10.1136/bjo.57.12.897 Giovannoni, 1997, Raised serum nitrate and nitrite levels in patients with multiple sclerosis, J. Neurol. Sci., 145, 77, 10.1016/S0022-510X(96)00246-8 Giovannoni, 1999, Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease, Mult. Scler., 5, 335, 10.1177/135245859900500506 Giovannoni, 2000, Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis, Eur. Neurol., 44, 222, 10.1159/000008241 Hauser, 2008, B-cell depletion with rituximab in relapsing-remitting multiple sclerosis, N. Engl. J. Med., 358, 676, 10.1056/NEJMoa0706383 Ingle, 2005, Is inflammation important in early PPMS? A longitudinal MRI study, J. Neurol. Neurosurg. Psychiatry., 76, 1255, 10.1136/jnnp.2004.036590 Kahn, 1990, Urinary “oligoclonal” bands in AIDS, Clin. Chem., 36, 174, 10.1093/clinchem/36.1.174 Kappos, 1999, Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group, Lancet, 353, 964, 10.1016/S0140-6736(98)03053-0 Kelly, 1991, Prognostic significance of paraproteinaemia in rheumatoid arthritis, Ann. Rheum. Dis., 50, 290, 10.1136/ard.50.5.290 Kurtzke, 1983, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 33, 1444, 10.1212/WNL.33.11.1444 Lublin, 1996, Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology, 46, 907, 10.1212/WNL.46.4.907 Magliozzi, 2007, Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology, Brain, 130, 1089, 10.1093/brain/awm038 McFarland, 2008, The B cell—old player, new position on the team, N. Engl. J. Med., 358, 664, 10.1056/NEJMp0708143 Mehta, 1991, Increased free light chains in the urine from patients with multiple sclerosis, Neurology, 41, 540, 10.1212/WNL.41.4.540 Miller, 1996, Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force, Ann. Neurol., 39, 6, 10.1002/ana.410390104 Murray, 1990, Analysis of aqueous humor immunoglobulin G in uveitis by enzyme-linked immunosorbent assay, isoelectric focusing, and immunoblotting, Invest. Ophthalmol. Vis. Sci., 31, 2129 Pezzoli, 1987, Bence Jones proteinuria in multiple sclerosis, Clin. Chem., 33, 1923, 10.1093/clinchem/33.10.1923 Poser, 1983, New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann. Neurol., 13, 227, 10.1002/ana.410130302 Presslauer, 2008, Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis, J. Neurol., 255, 1508, 10.1007/s00415-008-0954-z Rinker, 2006, Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis, Neurology, 67, 1288, 10.1212/01.wnl.0000238107.31364.21 Rudick, 1985, Multiple sclerosis: free light chains in cerebrospinal fluid, Neurology, 35, 1443, 10.1212/WNL.35.10.1443 Sormani, M., Rovaris, M., Comi, G., Filippi, M. 2009. A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Neurology. Tintore, 2008, Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis, Neurology, 13, 1079, 10.1212/01.wnl.0000280576.73609.c6 Tsai, 1992, Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis, Ann. Rheum. Dis., 51, 168, 10.1136/ard.51.2.168